Production currently suspended due to Covid-19.
Save up to 12% on Emergent Biosolutions’ vaccines
Save up to 12% on Vivotif® Oral Typhoid vaccine
Enjoy the lowest prices on all of Emergent's vaccines.
Save up to 6.5% for Vaxchora® vaccine
Enjoy the lowest prices on all of Emergent's vaccines.
Conveniently purchase directly from https://emergenttravelhealth.com
Create a Emergent Biosolutions account and select PBG via PracticeWell as the GPO.
Rebates earned on all Vivotif® and Vaxchora® purchases
These generous rebates lower your overall cost.
No minimum purchase necessary for contract discount
Free shipping
Previously, Emergent BioSolutions focused on developing, manufacturing, and commercializing specialty vaccines that protect against existing and emerging infectious diseases. In 2018, Emergent BioSolutions was acquired by Emergent Solutions. Through the acquisition, Vivotif®, the only oral vaccine licensed by the U.S. Food and Drug Administration (FDA) for the prevention of typhoid fever (Typhoid Vaccine Live Oral Ty21a) and Vaxchora® Cholera Vaccine (Live, Oral), were acquired.
Vivotif® is a vaccine for typhoid fever. Taken orally, the vaccine is delivered to the mucosal surface of the gastrointestinal tract—the largest immunologic organ in the body. The vaccine provides sustained efficacy for 5 years.
Vaxchora ® is a vaccine indicated for active immunization against disease caused by Vibrio cholerae serogroup O1 in adults 18 through 64 years of age traveling to cholera-affected areas.
We make it easy to do more for your patients and practice.